AMGN: Amgen Stock Future Looks Bright for Investors

Amgen released earnings that put a smile on investor's faces, and Amgen stock looks like a solid buy for the long term More 

3 Biotechs to Buy and 1 to Sell Now

Biotechs are a sector where the whisper of FDA approval can send stocks soaring or falling. Here are 4 biotech stocks to watch for 2014, including 3 buys More 

3 Biotech Stocks Where Momentum is Alive and Well

If you are looking around the biotech space for the next knockout winner, take a look at these 3 contenders for the next big runup. More 

ILMN Stock – The New Illumina Human Genome Machine Is a Game Changer

Illumina says it has developed a DNA sequencing machine that can scan a genome for under $1,000, sending ILMN stock higher. More 

5 Biotech Stocks With Big Catalysts on the Horizon

Announcements from, or about, these biotech stocks could greatly inflate their values ... or completely deflate them. More 

XBI – Be Careful With This Biotech ETF After Its Violent Breakout

After last week's breakout and rally, the SPDR S&P Biotech ETF (XBI) is well overbought. Traders must closely watch Intercept Pharmaceuticals (ICPT). More 

GILD: Get on While Biotech Remains Hot

The bulls seemingly are unwilling to cast off biotech. And among the sector's biggest stocks, Gilead Sciences (GILD) has the most appealing setup. More